KYP-2047, an Inhibitor of Prolyl-Oligopeptidase, Reduces GlioBlastoma Proliferation through Angiogenesis and Apoptosis Modulation

Lignende værker

• The Inhibition of Prolyl Oligopeptidase as New Target to Counteract Chronic Venous Insufficiency: Findings in a Mouse Model
  af: Casili, Giovanna, et al.
  Udgivet: (2020)
• A prolyl oligopeptidase inhibitor, KYP-2047, reduces α-synuclein protein levels and aggregates in cellular and animal models of Parkinson's disease
  af: Myöhänen, TT, et al.
  Udgivet: (2012)
• The beneficial effect of a prolyl oligopeptidase inhibitor, KYP-2047, on alpha-synuclein clearance and autophagy in A30P transgenic mouse
  af: Savolainen, Mari H., et al.
  Udgivet: (2014)
• Effect of a Product Containing Xyloglucan and Pea Protein on a Murine Model of Atopic Dermatitis
  af: Campolo, Michela, et al.
  Udgivet: (2020)
• Synergic Therapeutic Potential of PEA-Um Treatment and NAAA Enzyme Silencing In the Management of Neuroinflammation
  af: Casili, Giovanna, et al.
  Udgivet: (2020)